Key Highlights

  • Shares fell 11.83% to USD 0.2981 in pre-market trading on November 4, 2026.
  • The implied Tuesday close was about USD 0.3381 (calculated), so the decline equals USD 0.0400.
  • A registered direct offering priced on October 19, 2026 raised about USD 3.75 million at USD 1.60 per share and Warrant package.
  • First half 2026 Revenue was USD 12.94 million, compared with USD 10.27 million a year earlier.
  • First half 2026 Net Income was USD 1.01 million, versus a net loss of USD 1.98 million.

What Weighed on INLIF Before the Open (down USD 0.0400, 11.83%)

INLIF (NASDAQ:INLF) slid 11.83% to USD 0.2981 in pre-market trading on November 4, 2026, against the Tuesday, November 3, 2026 close. The screen figures imply a prior close of about USD 0.3381 (calculated), which means the shares trade roughly 81% below the USD 1.60 offering price (calculated).

No company announcement dated November 2, 3 or 4, 2026 was identified. The most relevant backdrop is the structure of the October offering, whose warrants include price based adjustments that can increase the share count when the stock trades lower. That link is an inference and not a confirmed cause.

Offering and Warrant Terms

According to a company press release dated October 19, 2026, the registered direct offering covered 435,000 Class A ordinary shares and pre-funded warrants for up to 1,908,750 shares, for gross proceeds of about USD 3.75 million. Each share or pre-funded warrant came with a Series A, a Series B and a Series C warrant, with closing expected on or about October 20, 2026.

Series A and B warrants carry a USD 1.60 exercise price and a one time downward reset on the twentieth trading day after closing, which falls in mid November 2026 (calculated). Series C warrants are exercisable at USD 0.0001 per share for a number of shares set by a price based adjustment over the first ten trading days, a period that ended around November 3, 2026 (calculated). The company has not disclosed the outcome.

Business Background and Recent Results

INLIF is a Cayman Islands company based in Quanzhou, China, whose operating entity Ewatt makes manipulator arms for injection molding machines. Since 2025 it has added automation equipment for the lithium battery and energy storage sector, and in the first half of 2026 it began early research on humanoid robots that have not yet been commercialised.

For the six months ended June 30, 2026, revenue was USD 12.94 million, against USD 10.27 million a year earlier, an increase of about 26.01% (calculated), with net income of USD 1.01 million versus a net loss of USD 1.98 million. Full year 2025 revenue was USD 18.41 million with a net loss of USD 5.45 million, while 2024 revenue was USD 15.80 million with net income of USD 1.63 million.

Balance Sheet and Risks

Before the offering, the company had 1,046,390 Class A and 43,908 Class B ordinary shares outstanding. The offering document showed 3,390,140 Class A shares assuming full exercise of the pre-funded warrants, and 30,458,162 if all ordinary warrants were also exercised, which illustrates the potential for heavy dilution.

Nasdaq notified the company in October 2025 about the minimum bid price, and compliance was restored on April 22, 2026. With the price now near USD 0.30, that issue could return. As a penny stock, INLIF can be volatile, thinly traded and prone to sharp reversals.

What to Watch Next

Key items are any disclosure of the warrant reset or the Series C share issuance, further Capital raising, and a fresh Nasdaq deficiency notice. Operating updates on the manipulator arm business, battery automation orders and humanoid robot research would also help frame results ahead of the next half year report.